Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10419
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHaase, Michaelen
dc.contributor.authorBellomo, Rinaldoen
dc.contributor.authorBaldwin, Ian Cen
dc.contributor.authorHaase-Fielitz, Anjaen
dc.contributor.authorFealy, Nigel Gen
dc.contributor.authorDavenport, Piersen
dc.contributor.authorMorgera, Stanislaoen
dc.contributor.authorGoehl, Hermannen
dc.contributor.authorStorr, Markusen
dc.contributor.authorBoyce, Neilen
dc.contributor.authorNeumayer, Hans-Hellmuten
dc.date.accessioned2015-05-15T23:51:47Z
dc.date.available2015-05-15T23:51:47Z
dc.date.issued2007-08-01en
dc.identifier.citationAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation; 50(2): 296-304en
dc.identifier.govdoc17660031en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10419en
dc.description.abstractSepsis is the leading cause of acute renal failure. Intermittent hemodialysis (IHD) is a common treatment for patients with acute renal failure. However, standard hemodialysis membranes achieve only little diffusive removal of circulating cytokines. Modified membranes may enable both successful IHD treatment and simultaneous diffusive cytokine removal.Double-blind, crossover, randomized, controlled, phase 1 trial.Tertiary intensive care unit. 10 septic patients with acute renal failure according to RIFLE class F.Each patient was treated with 4 hours of high-cutoff (HCO)-IHD and 4 hours of high-flux (HF)-IHD.We chose relative change in plasma interleukin 6 (IL-6) concentrations from baseline to 4 hours as the primary outcome for effective cytokine removal. We measured plasma and effluent concentrations of cytokines (IL-6, IL-8, IL-10, and IL-18) and albumin.Median age was 53 years (25(th) to 75(th) percentiles, 43 to 71 years). Both treatments achieved equal control of uremia. Four hours of HCO-IHD accomplished a greater decrease in plasma IL-6 levels (-30.3%) than 4 hours of HF-IHD (1.1%; P = 0.05). HCO-IHD, but not HF-IHD, achieved substantial diffusive clearance of several cytokines (IL-6, 14.1 mL/min; IL-8, 75.2 mL/min; and IL-10, 25.5 mL/min). Such clearance also was associated with greater relative decreases in plasma IL-8 and IL-10 levels in favor of HCO-IHD (P = 0.02, P = 0.04). We found significantly greater relative changes from prefilter to postfilter plasma IL-6, IL-8, and IL-10 values in favor of HCO-IHD (P = 0.02, P = 0.01, P < 0.01). During HCO-IHD, cumulative albumin loss into the effluent was 7.7 g (25(th) to 75(th) percentiles, 4.8 to 19.6) versus less than 1.0 g for HF-IHD (P < 0.01).Small phase 1 trial.In septic patients with acute renal failure, HCO-IHD achieved simultaneous uremic control and diffusive cytokine clearances and a greater relative decrease in plasma cytokine concentrations than standard HF-IHD.en
dc.language.isoenen
dc.subject.otherAcute Kidney Injury.blood.etiology.therapyen
dc.subject.otherAdulten
dc.subject.otherAgeden
dc.subject.otherCross-Over Studiesen
dc.subject.otherCytokines.blooden
dc.subject.otherDouble-Blind Methoden
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMembranes, Artificialen
dc.subject.otherMiddle Ageden
dc.subject.otherRenal Dialysis.instrumentation.standardsen
dc.subject.otherSepsis.blood.complications.therapyen
dc.titleHemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.en
dc.typeJournal Articleen
dc.identifier.journaltitleAmerican journal of kidney diseases : the official journal of the National Kidney Foundationen
dc.identifier.affiliationIntensive Care Unit, Austin Hospital, University of Melbourne, Australiaen
dc.identifier.doi10.1053/j.ajkd.2007.05.003en
dc.description.pages296-304en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/17660031en
dc.type.austinJournal Articleen
local.name.researcherBaldwin, Ian C
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Nov 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.